Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug2673 | Olaparib Oral Tablet [Lynparza] Wiki | 1.00 |
| drug3871 | TBD Compound 3 Wiki | 1.00 |
| drug3870 | TBD Compound 2 Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D002289 | Carcinoma, Non-Small-Cell Lung NIH | 0.45 |
| D008175 | Lung Neoplasms NIH | 0.29 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| HP:0030358 | Non-small cell lung carcinoma HPO | 0.45 |
| HP:0100526 | Neoplasm of the lung HPO | 0.29 |
Navigate: Correlations HPO
There is one clinical trial.
The federal government of Malaysia implemented a nationwide Movement Control Order (MCO) to control the COVID-19 outbreak. The MCO, however, has been found to have a negative impact on people's mental wellbeing. Interventions that can improve mental health under restricted movement condition is urgently. The present study investigated the impact of a brief, online mindfulness-based intervention on mental health using two-arm randomized controlled trial design. A total of 161 participants self-reported their feeling, anxiety, psychological insecurity, and well-being at baseline (T1) and post-test (T2), while 61 of them answered the same set of measures and the fear of COVID-19 scale in a follow-up study two weeks later (T3).
Description: This is being measured with the Subject Unit of Distress Scale.
Measure: Changes of Subjective Unit of Distress Time: It was measured at pre-intervention, post-intervention (through intervention completion, on average 10 minutes), and 2-week follow up.Description: This is being measured with the GAD-7 questionnaire.
Measure: Changes of Anxiety Scores Time: It was being It was measured at pre-intervention, post-intervention (through intervention completion, on average 10 minutes), and 2-week follow up.Description: This is being measured with the Psychological Insecurity Scale.
Measure: Changes of Psychological Insecurity Time: It was being It was measured at pre-intervention, post-intervention (through intervention completion, on average 10 minutes), and 2-week follow up.Description: This is being measured with the WHO-5 Well-being Index questionnaire.
Measure: Changes of General Well-being Time: It was being It was measured at pre-intervention, post-intervention (through intervention completion, on average 10 minutes), and 2-week follow up.Description: This is being measured with the Fear of COVID-19 Scale.
Measure: Fear of COVID-19 Time: It was being measured at 2-week follow up.Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports